Skandinaviska Enskilda Banken AB publ Has $56.80 Million Stock Holdings in HCA Healthcare, Inc. $HCA

Skandinaviska Enskilda Banken AB publ reduced its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 3.3% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 133,269 shares of the company’s stock after selling 4,616 shares during the period. Skandinaviska Enskilda Banken AB publ’s holdings in HCA Healthcare were worth $56,799,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Cerity Partners LLC grew its position in HCA Healthcare by 13.1% in the 3rd quarter. Cerity Partners LLC now owns 43,920 shares of the company’s stock worth $18,719,000 after purchasing an additional 5,092 shares during the last quarter. Savant Capital LLC grew its position in HCA Healthcare by 37.7% during the third quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock worth $1,938,000 after buying an additional 1,246 shares in the last quarter. Swiss National Bank raised its holdings in HCA Healthcare by 4.3% in the 2nd quarter. Swiss National Bank now owns 558,900 shares of the company’s stock valued at $214,115,000 after acquiring an additional 23,100 shares in the last quarter. Sector Gamma AS increased its position in shares of HCA Healthcare by 36.0% during the third quarter. Sector Gamma AS now owns 10,883 shares of the company’s stock valued at $4,638,000 after purchasing an additional 2,883 shares during the period. Finally, National Pension Service lifted its position in HCA Healthcare by 2.9% in the third quarter. National Pension Service now owns 626,585 shares of the company’s stock worth $267,051,000 after purchasing an additional 17,531 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

Shares of NYSE:HCA opened at $539.91 on Tuesday. The business has a fifty day moving average of $483.90 and a 200-day moving average of $450.93. The firm has a market cap of $120.73 billion, a PE ratio of 19.02, a price-to-earnings-growth ratio of 1.66 and a beta of 1.36. HCA Healthcare, Inc. has a twelve month low of $295.00 and a twelve month high of $552.90.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, beating the consensus estimate of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The firm had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. During the same quarter last year, the company posted $6.22 EPS. The company’s quarterly revenue was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be paid a $0.78 dividend. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s payout ratio is 10.15%.

Insider Activity

In other news, SVP Jennifer Berres sold 8,020 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the completion of the sale, the senior vice president owned 11,993 shares in the company, valued at $6,171,357.94. The trade was a 40.07% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the completion of the transaction, the senior vice president directly owned 44,379 shares in the company, valued at approximately $22,411,395. The trade was a 8.27% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 13,520 shares of company stock valued at $6,894,067 over the last 90 days. 1.30% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on HCA shares. KeyCorp set a $503.00 price objective on shares of HCA Healthcare in a report on Wednesday, January 28th. Morgan Stanley downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 price objective on the stock. in a report on Monday, December 15th. Sanford C. Bernstein set a $541.00 target price on HCA Healthcare in a research report on Monday, February 9th. Deutsche Bank Aktiengesellschaft upped their price target on HCA Healthcare from $500.00 to $558.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. Finally, Weiss Ratings restated a “buy (b)” rating on shares of HCA Healthcare in a research note on Monday, December 29th. Sixteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $523.27.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.